Dr Jamie Bellinge is a clinician-researcher specialising in Nuclear Medicine and Molecular Imaging, with a particular interest in the imaging of vascular diseases. His research focuses on developing novel, and advancing established, molecular imaging techniques to improve diagnosis, prognostication, and risk stratification in cardiovascular disease—aiming ultimately to reduce its burden on the Australian population.

Dr Bellinge graduated with a medical degree in 2015 and completed his PhD in 2022, focusing on molecular imaging of vascular disease. He undertook his clinical training in Western Australia, completing the RACP examinations in 2022 before commencing sub-specialty training in Nuclear Medicine in 2023.

In 2024, Dr Bellinge was awarded a Fulbright Scholarship and an RACP Research Establishment Fellowship to undertake research at Massachusetts General Hospital and Harvard Medical School. He is committed to a career in clinical academia, driven by a passion to advance Nuclear Medicine both in Western Australia and nationally, for the benefit of all Australians.